Roy van der Meel

Roy van der Meel is an Associate Professor of Precision Medicine at the Biomedical Engineering Department of Eindhoven University of Technology (TU/e). His research focuses on developing RNA-based nanotherapeutics to regulate immune responses with precision, particularly targeting myeloid cells and bone marrow progenitors. He holds a Ph.D. from Utrecht University (2013) and conducted postdoctoral research at the University Medical Center Utrecht and the University of British Columbia. His work is supported by grants including NWO Veni (2015), Marie Skłodowska-Curie Action (2015), and NWO Vidi (2022).

Education:

• M.Sc. Biomedical Sciences and Drug Innovation, Utrecht University (2009)
• Ph.D. in Pharmaceutics, Utrecht University (2013)

Research Interests:

• Design of lipid nanoparticles for mRNA delivery
• Targeted nanomedicines for tumor inhibition and angiogenesis control
• Myeloid cell-based therapies for sepsis and autoimmune disorders
• Machine learning-driven nanoparticle optimization

Grants & Awards:

• NWO Vidi Grant (2022)
• NWO Veni Grant (2015)
• Marie Skłodowska-Curie Global Fellowship (2015)
• NVBMB Prize (2023)

Lab/Teams: Leads the van der Meel Lab at TU/e, focusing on translational nanomedicine and immune system engineering. Collaborates with institutions like University Medical Center Utrecht and University of British Columbia.